PEPTIDES·INDEX
72 peptides412 listingsUpdated 56m agoBuild My Stack
Library

ProstamaxLongevity

Khavinson peptide bioregulator studied for prostate tissue.

Rating1/5SpeculativeHuman dataSafety
Compare prices — from $45.00
StatusResearch only
FDA-approvedNO
PrescriptionNO
From$45.00

Overview

Prostamax is a synthetic tetrapeptide, lysine-glutamate-aspartate-proline (Lys-Glu-Asp-Pro / KEDP), from Vladimir Khavinson's "peptide bioregulator" program at the St. Petersburg Institute of Bioregulation and Gerontology, positioned as a regulator of prostate tissue. Its published record is small and entirely preclinical: rat prostate explant cultures, and chromatin studies on lymphocytes that were drawn from elderly donors and treated in a dish — the donors themselves were never given the peptide. Nearly all of it comes from the Khavinson group and a collaborating Tbilisi lab, there are no human trials, and it is not FDA-evaluated; it is sold only as a research chemical.

Sources

Starting references for the library summary. These are not dosing instructions or medical advice.

For research-use educational context only. Not medical advice and not a recommendation to use any compound. Consult a qualified healthcare professional before any health decision.